SK biopharmaceuticals

에스케이바이오팜KRX: 326030· Fiscal year 2025· skbp.com ↗

Average salary
$90.5K
₩120.5M
▲ 21.8% vs 2024
Employees
272
▲ 2.6% vs 2024
Average tenure
6.3 yrs

Estimated take-home of this pay:$5.7K / monthCalculate →

Workplace

Women's pay (men = 100)84
Women among staff50%
Contract staff8.5%

Recent official filings

Quick read

  • Average pay is 97% above the median of the companies we track.
  • Average pay rose 21.8% from 2024.
  • Headcount grew by 7 (2.6%) from 2024.
  • Ranks #16 of 166 Services & Education companies in this country by pay.
  • Revenue grew 29.1% year over year.
  • Revenue has grown two years in a row.
  • Operating margin was 28.9% in 2025.
  • Operating loss of $28.1M in 2023.

Last 3 years

Revenue
$266.4M2023$411.0M2024$530.5M2025
Operating income
-$28.2M2023$72.3M2024$153.1M2025

See the share price on Naver Finance ↗

Investor metrics

2025
Revenue per employee
$1.9M
Net profit per employee
$697.2K
Operating margin
28.9%
Net margin
35.8%
ROE
30.7%
Debt-to-equity
45.0%
Equity ratio
69.0%

Per-employee figures use the company headcount, so they run high for groups with many subsidiaries. Not investment advice.

Similar companies

USD at ₩1,332.22 per $1 (2026-11-19, ExchangeRate-API)

Source: DART (Financial Supervisory Service, Korea)

Not investment advice. Figures come from public filings and may contain errors.